177 related articles for article (PubMed ID: 31261651)
1. Fluorine-18 Labeled Fluorofuranylnorprogesterone ([
Basuli F; Zhang X; Blackman B; White ME; Jagoda EM; Choyke PL; Swenson RE
Molecules; 2019 Jun; 24(13):. PubMed ID: 31261651
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.
Zhou D; Lin M; Yasui N; Al-Qahtani MH; Dence CS; Schwarz S; Katzenellenbogen JA
J Labelled Comp Radiopharm; 2014 May; 57(5):371-7. PubMed ID: 24861984
[TBL] [Abstract][Full Text] [Related]
3. Fully-automated synthesis of 16β-(18)F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer.
Lazari M; Lyashchenko SK; Burnazi EM; Lewis JS; van Dam RM; Murphy JM
Appl Radiat Isot; 2015 Sep; 103():9-14. PubMed ID: 26046518
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of
Antunes IF; Dost RJ; Hoving HD; van Waarde A; Dierckx RAJO; Samplonius DF; Helfrich W; Elsinga PH; de Vries EFJ; de Jong IJ
J Nucl Med; 2021 Aug; 62(8):1140-1145. PubMed ID: 33517325
[TBL] [Abstract][Full Text] [Related]
5. Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using "radio-fluorination on the Sep-Pak" method.
Basuli F; Zhang X; Jagoda EM; Choyke PL; Swenson RE
J Labelled Comp Radiopharm; 2018 Jun; 61(8):599-605. PubMed ID: 29575176
[TBL] [Abstract][Full Text] [Related]
6. Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.
Dehdashti F; Laforest R; Gao F; Aft RL; Dence CS; Zhou D; Shoghi KI; Siegel BA; Katzenellenbogen JA; Welch MJ
J Nucl Med; 2012 Mar; 53(3):363-70. PubMed ID: 22331216
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
[TBL] [Abstract][Full Text] [Related]
8. Fully automated synthesis of [(18) F]fluoro-dihydrotestosterone ([(18) F]FDHT) using the FlexLab module.
Ackermann U; Lewis JS; Young K; Morris MJ; Weickhardt A; Davis ID; Scott AM
J Labelled Comp Radiopharm; 2016 Aug; 59(10):424-8. PubMed ID: 27378195
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.
Beattie BJ; Smith-Jones PM; Jhanwar YS; Schöder H; Schmidtlein CR; Morris MJ; Zanzonico P; Squire O; Meirelles GS; Finn R; Namavari M; Cai S; Scher HI; Larson SM; Humm JL
J Nucl Med; 2010 Feb; 51(2):183-92. PubMed ID: 20080885
[TBL] [Abstract][Full Text] [Related]
10. Specific
Larimer BM; Dubois F; Bloch E; Nesti S; Placzek M; Zadra G; Hooker JM; Loda M; Mahmood U
J Nucl Med; 2018 Oct; 59(10):1538-1543. PubMed ID: 29853654
[TBL] [Abstract][Full Text] [Related]
11. Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.
Salem K; Kumar M; Kloepping KC; Michel CJ; Yan Y; Fowler AM
Am J Nucl Med Mol Imaging; 2018; 8(2):119-126. PubMed ID: 29755845
[TBL] [Abstract][Full Text] [Related]
12. Serial [
Boers J; Venema CM; de Vries EFJ; Hospers GAP; Boersma HH; Rikhof B; Dorbritz C; Glaudemans AWJM; Schröder CP
Eur J Cancer; 2021 Feb; 144():151-161. PubMed ID: 33341447
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and Isoform Specificity of
Salem K; Kumar M; Yan Y; Jeffery JJ; Kloepping KC; Michel CJ; Powers GL; Mahajan AM; Fowler AM
J Nucl Med; 2019 Feb; 60(2):220-226. PubMed ID: 30030339
[TBL] [Abstract][Full Text] [Related]
14. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.
Zhou D; Sharp TL; Fettig NM; Lee H; Lewis JS; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 2008 Aug; 35(6):655-63. PubMed ID: 18678350
[TBL] [Abstract][Full Text] [Related]
16. Facile and rapid one-step radiosynthesis of [(18)F]BAY94-9172 with a new precursor.
Wang H; Shi H; Yu H; Jiang S; Tang G
Nucl Med Biol; 2011 Jan; 38(1):121-7. PubMed ID: 21220135
[TBL] [Abstract][Full Text] [Related]
17. Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid
Basuli F; Zhang X; Phelps TE; Jagoda EM; Choyke PL; Swenson RE
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867358
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Simplified Methods for Quantification of
Kramer GM; Yaqub M; Vargas HA; Schuit RC; Windhorst AD; van den Eertwegh AJM; van der Veldt AAM; Bergman AM; Burnazi EM; Lewis JS; Chua S; Staton KD; Beattie BJ; Humm JL; Davis ID; Weickhardt AJ; Scott AM; Morris MJ; Hoekstra OS; Lammertsma AA
J Nucl Med; 2019 Sep; 60(9):1221-1227. PubMed ID: 30850488
[No Abstract] [Full Text] [Related]
19. Positron tomographic assessment of androgen receptors in prostatic carcinoma.
Dehdashti F; Picus J; Michalski JM; Dence CS; Siegel BA; Katzenellenbogen JA; Welch MJ
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):344-50. PubMed ID: 15726353
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.
Katzenellenbogen JA
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32718075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
